Summary by Futu AI
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares on 04/02/2024, as per the latest filing. These shares, with an aggregate market value of $100,942.19, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This upcoming sale follows a series of transactions over the past three months, where a total of 111,717 shares were sold by Borgeson, generating gross proceeds of $1,297,128.07.